About the Project
The GW4 BioMed3 Doctoral Landscape Programme is offering up to 18 MRC funded studentships across a range of biomedical disciplines, with a start date of October 2027.
These four-year studentships provide funding for fees and stipend at the rate set by the UKRI, as well as other research training and support costs, and are available to UK and International students.
About the GW4 BioMed3 Doctoral Landscape Programme
The partnership brings together the Universities of Bath, Bristol, Cardiff (lead), and Exeter to train, support and develop graduates with strong research, critical analysis, creative problem solving and translational skills, equipping them for careers in the UK and globally. Our vision aligns research and skills development with UK Government priorities for the life sciences sector, while nurturing contributions to improve health outcomes and the economy worldwide.
Students will have access to the combined research strengths, training expertise, and resources of the four research-intensive universities, with opportunities to participate in interdisciplinary science. GW4 BioMed has previously awarded over 100 studentships across 6 cohorts in its first phase, along with 99 students over 5 cohorts in its second phase. GW4 BioMed3 will be our third, starting in October 27.
This project is in competition for place with the projects across the MRC GW4 BioMed3 Doctoral Landscape Award studentships. There are a total of 18 studentships available across the partnership.
The 134 projects available for application, are aligned to the following themes;
- Cardiometabolic Disease
- Infection, Immunity, and Antimicrobial Resistance
- Neuroscience and Mental Health
- Population Health Sciences
Applications open on Wednesday 9 September and close at 5.00pm on Wednesday 21st October 2026. Please note that we may close the application process before the stated deadline if an unprecedented number of applications are received– check our website for details.
Studentships will be 4 years full time. Part-time study may also be available.
Project Information
Schizophrenia is a severe psychiatric disorder with debilitating effects on a patient's quality of life. Because current medications do not work well, we need to study its molecular cause to develop new therapeutics. Recent research identified a number of genetic mutations in Schizophrenia patients called “rare coding variants.” These mutations change the proteins they produce, but for many of them, we do not yet know the functional consequences. In this project we will study the functions of the rare coding variants using zebrafish and compare the results with mouse models of equivalent mutations and human post-mortem brain tissue.
Funding Notes
A GW4 BioMed3 MRC DTP studentship includes full UK tuition fees, a stipend at the minimum UKRI rate (£21,805 p.a for 2026/27 updated each year). Additional Research & Training Support funding of up to £5,000 per annum is also available. Funding arrangements will be adjusted pro-rata for part-time studentships.
This is a Preview Listing…
You must sign in to see the full job description, and to apply.
Manage / Upgrade this job to a Full Job Listing.
Find Your Best Opportunity
Tell them AcademicJobs.com sent you!